Yu-Qing Xie

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Low Density Lipoprotein

Helicobacter Pylori Infection

Immune Response

Top Venues

Nature biotechnology

Science advances

Science (New York, N.Y.)

Nature biomedical engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Zhao, Jiangqing Chen, Massimo Andreatta, Bing Feng, Yu-Qing Xie, Mathias Wenes, Yi Wang, Min Gao, Xiaomeng Hu, Pedro Romero, Santiago J Carmona, Jie Sun, Yugang Guo, Li Tang
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases. Nature biotechnology (2024)
Qiqun Zeng, Sadegh Saghafinia, Agnieszka Chryplewicz, Nadine Zangger, Lucine Christe, Yu-Qing Xie, Jeremy Guillot, Simge Yucel, Pumin Li, José A Galván, Eva Karamitopoulou, Inti Zlobec, Dalya Ataca, Fleuriane Gallean, Peng Zhang, José Antonio Rodriguez-Calero, Mark Rubin, Melanie Tichet, Krisztian Homicsko, Douglas Hanahan
Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion. Science (New York, N.Y.) 378 (6621) (2022)
Kewen Lei, Armand Kurum, Murat Kaynak, Lucia Bonati, Yulong Han, Veronika Cencen, Min Gao, Yu-Qing Xie, Yugang Guo, Mélanie T M Hannebelle, Yangping Wu, Guanyu Zhou, Ming Guo, Georg E Fantner, Mahmut Selman Sakar, Li Tang
Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy. Nature biomedical engineering (2021)
Yu Zhao, Yu-Qing Xie, Simon Van Herck, Sina Nassiri, Min Gao, Yugang Guo, Li Tang
Switchable immune modulator for tumor-specific activation of anticancer immunity. Science advances 7 (37) (2021)
Yugang Guo, Yu-Qing Xie, Min Gao, Yang Zhao, Fabien Franco, Mathias Wenes, Imran Siddiqui, Alessio Bevilacqua, Haiping Wang, Hanshuo Yang, Bing Feng, Xin Xie, Catherine M Sabatel, Benjamin Tschumi, Amphun Chaiboonchoe, Yuxi Wang, Weimin Li, Weihua Xiao, Werner Held, Pedro Romero, Ping-Chih Ho, Li Tang
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity. Nature immunology 22 (6) (2021)